4/A//SEC Filing
Kunin Audrey 4/A
Accession 0001437749-22-028439
CIK 0001389545other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 5:30 PM ET
Size
5.6 KB
Accession
0001437749-22-028439
Insider Transaction Report
Form 4/AAmended
Kunin Audrey
Chief Product Officer
Transactions
- Sale
Common Stock
2022-11-21$2.10/sh−5,960$12,545→ 1 total(indirect: See footnote)
Footnotes (4)
- [F1]On November 15, 2022, the common stock of NovaBay Pharmaceuticals, Inc. split 1-for-35, and is reflected accordingly in the number of shares sold.
- [F2]This transaction was executed in multiple trades at prices ranging from $2.09 to $2.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]The original Form 4, filed on November 23, 2022, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported that the reporting person beneficially owned no shares following the reported transaction when in fact the reporting person beneficially owned one share following the reported transaction.
- [F4]By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeother
Related Parties
1- filerCIK 0001738781
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 5:30 PM ET
- Size
- 5.6 KB